Loading the security overview…
Where the tokens are
| Quarter | Reported | EPS | EPS vs year ago | Revenue | Revenue vs year ago | Consensus EPS |
|---|---|---|---|---|---|---|
| Q2 FY26ended Jun 30, 2026 | Jul 31, 2026 | $2.03 | +290.4% | $16.99B | +10.2% | $3.60 |
| Q1 FY26ended Mar 31, 2026 | Apr 29, 2026 | $0.39 | −45.8% | $15.00B | +12.4% | $2.62 |
| Q4 FY25ended Dec 31, 2025 | — | $1.02 | — | $16.62B | +10.0% | — |
| Q3 FY25ended Sep 30, 2025 | — | $0.10 | −88.6% | $15.78B | +9.1% | — |
| Q2 FY25ended Jun 30, 2025 | — | $0.52 | −32.5% | $15.42B | +6.6% | — |
| Q1 FY25ended Mar 31, 2025 | — | $0.72 | −6.5% | $13.34B | +8.4% | — |
| Q4 FY24ended Dec 31, 2024 | — | −$0.02 | −104.3% | $15.10B | +5.6% | — |
| Q3 FY24ended Sep 30, 2024 | — | $0.88 | −12.0% | $14.46B | +3.8% |
Growth compares each quarter with the same fiscal quarter a year earlier, and is left blank where that quarter is missing or its figure was zero or a loss. Consensus is the estimate published before each report. It usually refers to adjusted EPS, so it is shown beside the GAAP figure rather than subtracted from it: the difference would not be a beat or a miss.
Figures describe AbbVie shares, not any token. As of Jul 31, 2026, from Massive's standardised financials and the earnings calendar.
| — |
| Q2 FY24ended Jun 30, 2024 | — | $0.77 | — | $14.46B | — | — |
| Q1 FY24ended Mar 31, 2024 | — | $0.77 | — | $12.31B | — | — |
| Q4 FY23ended Dec 31, 2023 | — | $0.46 | — | $14.30B | — | — |
| Q3 FY23ended Sep 30, 2023 | — | $1.00 | — | $13.93B | — | — |